Key terms
About DRTS
Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest DRTS news
Mar 12
12:25pm ET
Buy Rating Affirmed: Anticipating Alpha Tau Medical’s Clinical Milestones and Growth Potential in 2024
Mar 08
7:47am ET
Alpha Tau Medical Ltd (DRTS) Gets a Buy from Piper Sandler
Feb 22
8:30am ET
Seven new option listings on February 22nd
Dec 15
8:21am ET
Analysts Are Bullish on Top Healthcare Stocks: Roivant Sciences (ROIV), Alpha Tau Medical Ltd (DRTS)
Dec 15
8:11am ET
Analysts’ Top Healthcare Picks: Merit Medical Systems (MMSI), Bicycle Therapeutics (BCYC)
Dec 15
8:00am ET
Citi starts ‘innovative’ Alpha Tau with Buy rating
Dec 15
7:51am ET
Alpha Tau initiated with a Buy at Citi
Dec 15
7:51am ET
Alpha Tau initiated with bullish view at Citi, here’s why
No recent press releases are available for DRTS
DRTS Financials
Key terms
Ad Feedback
DRTS Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
DRTS Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range